Biotech news
Americas
The 2026 panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such as White & Case and Arnold & Porter, here’s who will be deciding this year’s winners. 10 April 2026
Biotech
The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech companies are racing to secure next-generation cancer treatments. 8 April 2026
Biotech
On World Health Day 2026, despite data trending in the right direction, systemic barriers continue to limit female inventors—and women's health is suffering. 7 April 2026
Europe
A Lisbon judge rejects a bid to strike out the case over a drafting issue, offering insight into the court’s high bar for early dismissal. 2 April 2026
Americas
A long-running patent clash over gene editing returns to a fundamental question, as a US court takes another look at the evidence. 30 March 2026
Biotech
The Swiss pharma giant targets next-generation anti-IgE biologics as it looks to extend its dominance in the market. 27 March 2026
Biotech
As the world moves past the pandemic, a massive legal struggle over the future of mRNA technology is just hitting its stride. LSIPR visualises the litigation defining the next era. 25 March 2026
Europe
The European Patent Office’s Technology Dashboard reveals only a slight increase in medtech filings, and drops in biotech and pharma, against an overall healthy backdrop. 24 March 2026
Americas
Janssen seeks injunctive relief after a forensic review uncovers mass downloads of trade secrets spanning oncology, neuroscience and immunology portfolios. 17 March 2026
Americas
Law firms, companies and individuals have been shortlisted across a range of categories, which this year include new awards for excellence in PTAB, trade secrets and medical device work. 2 March 2026